Dr. Max secures EUR 1,86 billion refinancing to support long-term growth
New seven-year financing package, strongly oversubscribed and supported by 19 international banks, strengthens Dr. Max's long-term financial flexibili...
Read more
New seven-year financing package, strongly oversubscribed and supported by 19 international banks, strengthens Dr. Max's long-term financial flexibili...
Read more
A milestone built on twenty years of expanding access to healthcare through trusted expertise, affordable prices healthcare solutions and care that st...
Read more
Issuer of the Bonds, the company Dr. Max Funding CR, s.r.o. (the "Issuer"), in accordance with the Base Prospectus approved by CNB decision ref. no. 2...
Read more
Please be informed that GLEBI HOLDINGS PLC, being the guarantor on Dr. Max Funding CR, s.r.o. bond issuances, changed its name to DR.MAX GROUP HOLDING...
Read more
Issuer of the Bonds, the company Dr. Max Funding CR, s.r.o. (the "Issuer"), in accordance with the Prospectus approved by CNB decision ref. no. 2024/1...
Read more
Completing a key acquisition in Italy, expansion of pharmacies in core markets, and investments in brand equity drove outstanding performance in 2023....
Read more
Dr.Max Funding CR, s.r.o. ("Issuer") in accordance with the chapter Underwriting and Sale, Article 2 Placing and Offering of Bonds of the Prospectus o...
Read more
During the last three weeks, Dr. Max has achieved a significant milestone in the diversification of its financing structure through the first-time iss...
Read more